"Icon Cancer Centre Wesley offers a full range of cancer treatments and blood disorder treatments. The centre is located on the first floor of The Wesley Medical Centre. Treatment options include chemotherapy, immunotherapy, targeted therapies, apheresis, stem cell collection and treatment for blood disorders. Icon has access to dedicated cancer care coordinators, scalp cooling systems, clinical trials, pharmacy and allied health services. There is no wait list, ensuring patients receive immediate access to consultation and treatment. The centre has a team of caring medical oncologists, haematologists, oncology nurses and administrative staff. Parking is available on-site at The Wesley Hospital."

During the past decade, Icon Cancer Care Wesley conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 14 clinical trials were completed, i.e. on average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 8 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Icon Cancer Care Wesley" #1 sponsor was "Pfizer" with 11 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "BeiGene" with 3 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Icon Cancer Care Wesley" #1 collaborator was "Astellas Pharma Inc" with 6 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 5 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Icon Cancer Care Wesley" are "Prostate Cancer" (5 trials), "Breast Cancer" (3 trials), "Cancer of the Prostate" (2 trials), "Anaplastic Large-Cell Lymphoma" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Icon Cancer Care Wesley" in a lesser frequency.

Most popular intervention types in "Icon Cancer Care Wesley" are "Drug" (27 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Enzalutamide" (5 trials), "Paclitaxel" (3 trials), "Zanubrutinib" (3 trials) and "Cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Icon Cancer Care Wesley" are 18 trials for "All" genders, 7 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Icon Cancer Care Wesley". undefined are not yet recruiting, 4 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Icon Cancer Care Wesley, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Icon Cancer Care Wesley, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".